In a new study, researchers report that expression of granulins (using AAV) corrects lysosome defects, inflammation, & lipofuscin in GRN-/- mice; These "findings have important implications for therapeutic development to treat FTD-GRN,
#Alzheimers, &
#Parkinsons"
www.cell.com/cell-reports...